Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky purchased 9,065 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average price of $26.49 per share, for a total transaction of $240,131.85. Following the purchase, the director owned 30,000 shares in the company, valued at $794,700. This trade represents a 43.30% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Alan Sebulsky also recently made the following trade(s):
- On Friday, June 12th, Alan Sebulsky acquired 8,435 shares of Parabilis Medicines stock. The shares were bought at an average cost of $27.67 per share, with a total value of $233,396.45.
- On Thursday, June 11th, Alan Sebulsky acquired 12,500 shares of Parabilis Medicines stock. The shares were bought at an average cost of $20.00 per share, with a total value of $250,000.00.
Parabilis Medicines Trading Down 0.7%
NASDAQ:PBLS opened at $25.85 on Friday. Parabilis Medicines, Inc. has a one year low of $24.51 and a one year high of $34.47.
Further Reading
- Five stocks we like better than Parabilis Medicines
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
